论文部分内容阅读
目的:分析布地奈德联合盐酸氨溴索雾化吸入治疗小儿支气管肺炎的临床价值。方法:将100例小儿支气管肺炎者分为2组。均实施常规治疗方案,对照组患者采取盐酸氨溴索雾化吸入治疗,以此为基准,观察组患者联合布地奈德雾化吸入治疗,分析治疗效果。结果:相较于对照组而言,观察组患者治疗效果显著更好,P<0.05.且治疗过程中,患者无显著不良反应。结论:对于小儿支气管肺炎者,使用盐酸氨溴索联合布地奈德雾化吸入治疗,临床效果显著,安全性强,值得进一步推广。
OBJECTIVE: To analyze the clinical value of budesonide combined with ambroxol hydrochloride inhalation in the treatment of bronchial pneumonia in children. Methods: 100 cases of children with bronchial pneumonia were divided into two groups. All the patients were treated with inhalation of ambroxol hydrochloride inhalation. The patients in the observation group were treated with inhalation of budesonide inhalation, and the treatment effect was analyzed. Results: Compared with the control group, the observation group patients treated with significantly better results, P <0.05, and the treatment process, the patient had no significant adverse reactions. Conclusion: In children with bronchial pneumonia, the use of ambroxol hydrochloride combined with budesonide inhalation therapy, the clinical effect is significant, safe and worthy of further promotion.